A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of Kadian NT (ALO-01) compared with
placebo for treating moderate to severe chronic pain over a 12 week period.